Literature DB >> 7447690

Polytetrafluoroethylene graft aneurysms: a report of five aneurysms.

L L Mohr, L L Smith.   

Abstract

True aneurysms have developed in nonreinforced, expanded polytetrafluoroethylene (PTFE). We report our experience in arterial reconstructions with PTFE in the legs of patients having symptomatic occlusive disease. Fifty-four femoropopliteal or femorotibial bypass operations were performed in 51 patients between January 1975 and December 1976. An unsuitable saphenous vein for a vascular conduit was found in 14 patients, and reconstruction was done with PTFE (IMPRA-graft). Two of the 14 PTFE grafts were composite and used a segment of saphenous vein. Aneurysmal dilation developed in five PTFE grafts (36%) in four patients three to 36 months following placement. Nonreinforced PTFE conduits as manufactured during 1975 and 1976 are unsatisfactory for use as limb arterial bypass grafts because of the high incidence of aneurysmal change. Those that are implanted must be followed up indefinitely because of late aneurysmal formation and rupture. Newer PTFE graft modifications should be used with caution.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447690     DOI: 10.1001/archsurg.1980.01380120037009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Clinical experience in 1040 patients with double-velour knitted Dacron vascular prostheses: With particular reference to dilatation and aneurysm formation.

Authors:  Denton A. Cooley; Aswath Subram; Dena P. Houchin
Journal:  Cardiovasc Dis       Date:  1981-09

2.  Thrombotic obstruction of a reinforced ringed expanded polytetrafluoroethylene graft caused by formation of a pseudoaneurysm at a nonanastomotic site: report of a case.

Authors:  K Akiyama; J Hirota; Y Shiina; A Ohkado; S Ohsawa; Y Kainuma
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Computed tomography of complications caused by manufacturing defects in synthetic grafts.

Authors:  Y Hertzanu; M Hirsch; L Golcman
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.